Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

594
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
594
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

458
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
458

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physics-informed, phenotype-based endotamponade selection in vitreoretinal surgery: current agents and emerging vitreous substitutes.

International journal of retina and vitreous·2026
Same author

Time motion study in the preoperative phase of cataract surgery.

Cirugia y cirujanos·2025
Same author

Comparative efficacy of photodynamic therapy (PDT), ranibizumab, aflibercept monotherapy, and combination therapies for polypoidal choroidal vasculopathy: a network meta-analysis of randomized controlled trials.

BMC ophthalmology·2025
Same author

Effects of cigarette smoking on retinal thickness and choroidal vascularity index: a systematic review and meta-analysis.

International journal of retina and vitreous·2025
Same author

Elucidating postoperative dynamics in tractional retinal detachment: a systematic review and meta-analysis of structural and functional outcomes following diabetic vitrectomy, including an analysis of postoperative complications.

BMC ophthalmology·2024
Same author

Safety and efficacy of human amniotic membrane plug transplantation in cases of macular hole. A scoping review.

International journal of retina and vitreous·2024

Related Experiment Video

Updated: Jul 10, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K

Choroidal Perfusion Changes After Vitrectomy for Myopic Traction Maculopathy.

Miguel A Quiroz-Reyes1, Erick A Quiroz-Gonzalez2, Miguel A Quiroz-Gonzalez1

  • 1Retina Department of Oftalmologia Integral ABC (Medical and Surgical Nonprofit Organization), National Autonomous University of Mexico, Ciudad de Mexico, Mexico.

Seminars in Ophthalmology
|November 22, 2023
PubMed
Summary

The choroidal vascularity index (CVI) did not differ preoperatively in myopic traction maculopathy (MTM) but decreased post-surgery. CVI and choriocapillaris flow area (CFA) changes after MTM surgery suggest choroidal alterations, but CVI is not a reliable surgical outcome predictor.

Keywords:
Central subfield thicknesschoriocapillaris flow areachoroidal vascularity indexmyopic traction maculopathypathologic myopia

More Related Videos

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
07:18

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography

Published on: February 18, 2022

1.8K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

3.2K

Related Experiment Videos

Last Updated: Jul 10, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
07:18

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography

Published on: February 18, 2022

1.8K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

3.2K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Vascular Biology

Background:

  • The choroid supplies the outer retina and is affected in retinal diseases like myopic traction maculopathy (MTM).
  • Choroidal thickness measurement has limitations; the choroidal vascularity index (CVI) offers quantitative vascular flow data.
  • CVI has been studied in various diseases but not extensively characterized in MTM.

Purpose of the Study:

  • To investigate CVI across different MTM stages.
  • To assess the impact of macular surgery on choroidal perfusion markers in surgically treated MTM.
  • To evaluate CVI as a potential biomarker for MTM surgical outcomes.

Main Methods:

  • Enhanced optical coherence tomography (OCT) imaging was used for 18 healthy myopic eyes and 46 MTM eyes.
  • Binarized OCT images allowed calculation of CVI, luminal choroidal area (LCA), and stromal choroidal area (SCA).
  • Choriocapillaris flow area (CFA) and central subfield thickness (CSFT) were also measured alongside CVI at baseline and postoperatively.

Main Results:

  • Postoperative vision significantly improved in MTM patients (p < 0.0001).
  • No significant baseline differences in CVI, CFA, or CSFT were found between control and MTM groups.
  • Postoperatively, CVI and CFA were significantly lower in the MTM group compared to controls (p ≤ 0.0001), with no significant differences among MTM stages.

Conclusions:

  • Preoperative CVI did not differ between healthy myopic eyes and MTM eyes.
  • Postoperative CVI and CFA were significantly reduced compared to controls, indicating choroidal changes after surgery.
  • CVI is not a reliable biomarker for surgical outcomes in MTM due to a lack of significant correlation with visual acuity.